Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

ENABLE (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy) (ENABLE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04049513
Recruitment Status : Recruiting
First Posted : August 8, 2019
Last Update Posted : September 30, 2019
Wellington Zhaotai Therapies Limited
Information provided by (Responsible Party):
Malaghan Institute of Medical Research

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : August 2026